Division of Cardiology, Internal Medicine Department, Ospedale Civico di Chivasso, Italy.
J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):242-6. doi: 10.2459/JCM.0b013e32834eecbf.
The insertion of a temporary pacemaker can be a lifesaving procedure in the emergency setting.
This is an observational monocentric study comparing echocardiography-guided temporary pacemaker via the right internal jugular vein to standard fluoroscopy-guided temporary pacemaker via the femoral vein; the procedure was tested for noninferiority.
Patients needing urgent pacing were consecutively enrolled. Primary efficacy endpoints were time to pacing and need for catheter replacement. Primary safety endpoint was a composite outcome of overall complications.
One hundred and six patients (77 ± 10 years) were enrolled: 53 underwent echocardiographic-guided and 53 fluoroscopy-guided temporary pacemaker. Baseline characteristics of the two groups of treatment were similar. Time to pacing was shorter in the echocardiography-guided than in the fluoroscopy-guided group (439 ± 179 vs. 716 ± 235 s; P<0.0001; power 100%). During the pacing (54 ± 35 h), there was a higher incidence of pacemaker malfunction in the fluoroscopy-guided group [15 vs. 3 patients; odds ratio (OR) 6.5, confidence interval (CI) 95% 1.9-29.7, P<0.001; power 5.7%] and there was a significantly lower incidence of complications in the echocardiography-guided temporary pacemaker group (6 vs. 22 patients; OR 0.18, CI 95% 0.06-0.49, P<0.001; echocardiography-guided temporary pacemaker events rate 0.1929 vs. fluoroscopy-guided temporary pacemaker events rate 1.398 per 100 person-hours paced, P<0.0001). In the standard group there was one death attributable to a temporary pacemaker complication (sepsis).
Echocardiography-guided temporary pacemaker is a well-tolerated procedure that could allow reliable insertion of a temporary pacemaker; therefore, it is a well-tolerated option in an emergency setting and in hospitals where fluoroscopy is not available.
在紧急情况下,插入临时起搏器可能是一项救命的程序。
这是一项观察性的单中心研究,比较了经右颈内静脉行超声心动图引导的临时起搏器与经股静脉行标准透视引导的临时起搏器;该方法经过非劣效性检验。
连续纳入需要紧急起搏的患者。主要疗效终点为起搏时间和需要更换导管。主要安全性终点是总体并发症的复合结果。
共纳入 106 例患者(77±10 岁):53 例行超声心动图引导,53 例行透视引导。两组患者的基线特征相似。起搏时间在超声心动图引导组比透视引导组短(439±179 比 716±235 秒;P<0.0001;功率 100%)。在起搏期间(54±35 小时),透视引导组起搏器故障的发生率较高[15 例比 3 例;比值比(OR)6.5,95%置信区间(CI)1.9-29.7,P<0.001;功率 5.7%],超声心动图引导临时起搏器组并发症发生率明显较低(6 例比 22 例;OR 0.18,95%CI 0.06-0.49,P<0.001;超声心动图引导临时起搏器事件率为 0.1929/100 人时起搏,透视引导临时起搏器事件率为 1.398/100 人时起搏,P<0.0001)。在标准组中,有 1 例死亡归因于临时起搏器并发症(败血症)。
超声心动图引导的临时起搏器是一种耐受良好的操作,可以可靠地插入临时起搏器;因此,在紧急情况下和没有透视设备的医院中,它是一种耐受良好的选择。